oxaprozin and betadex
oxaprozin has been researched along with betadex in 5 studies
Research
Studies (5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Cirri, M; Maestrelli, F; Mennini, N; Mura, P; Zerrouk, N | 1 |
| Aguzzi, C; Maestrelli, F; Mura, P; Viseras, C | 1 |
| Cirri, M; Maestrelli, F; Mennini, N; Mura, P | 2 |
| Cirri, M; Di Cesare Mannelli, L; Ghelardini, C; Maestrelli, F; Mennini, N; Mura, P | 1 |
Other Studies
5 other study(ies) available for oxaprozin and betadex
| Article | Year |
|---|---|
Improvement of oxaprozin solubility and permeability by the combined use of cyclodextrin, chitosan, and bile components.
Topics: Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrins; Bile; Caco-2 Cells; Chitosan; Cholagogues and Choleretics; Dehydrocholic Acid; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Synergism; Excipients; Humans; L-Lactate Dehydrogenase; Oxaprozin; Permeability; Propionates; Solubility; Ursodeoxycholic Acid | 2011 |
Hybrid systems based on "drug - in cyclodextrin - in nanoclays" for improving oxaprozin dissolution properties.
Topics: Aluminum Silicates; Anti-Inflammatory Agents; Bentonite; beta-Cyclodextrins; Clay; Cyclodextrins; Magnesium Compounds; Magnesium Silicates; Nanoparticles; Oxaprozin; Propionates; Silicon Compounds; Solubility | 2016 |
Analysis of physicochemical properties of ternary systems of oxaprozin with randomly methylated-ß-cyclodextrin and l-arginine aimed to improve the drug solubility.
Topics: Amino Acids; Anti-Inflammatory Agents; Arginine; beta-Cyclodextrins; Calorimetry, Differential Scanning; Chemical Phenomena; Oxaprozin; Pharmaceutical Solutions; Powders; Propionates; Solubility; X-Ray Diffraction; X-Rays | 2016 |
Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation.
Topics: Administration, Cutaneous; beta-Cyclodextrins; Chemistry, Pharmaceutical; Cyclodextrins; Drug Carriers; Humans; Lipids; Liposomes; Nanoparticles; Nanostructures; Oxaprozin; Particle Size; Permeability; Propionates; Skin; Skin Absorption; Solubility | 2016 |
Development and characterization of fast dissolving tablets of oxaprozin based on hybrid systems of the drug with cyclodextrins and nanoclays.
Topics: Aluminum Silicates; Animals; beta-Cyclodextrins; Clay; Drug Carriers; Nanoparticles; Oxaprozin; Propionates; Rats; Solubility; Tablets | 2017 |